Antibiotic resistance pattern of Flavobacterium meningosepticum.
D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002701:Chloramphenicol / Q000494:pharmacology; D002981:Clindamycin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D005417:Flavobacterium / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D007231:Infant, Newborn; D007525:Isoelectric Focusing; D012293:Rifampin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology; D001618:beta-Lactamases / Q000032:analysis; D047090:beta-Lactams
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D001618:beta-Lactamases; D013752:Tetracycline; D012293:Rifampin